# Camtek Ltd. (CAMT)

> Source: Nexqual · https://nexqual.com/CAMT · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Camtek Ltd. (CAMT), nexqual.com/CAMT" · informational, not investment advice.

**Price:** USD 119.48 (-10.23% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 133.09 · day 117.67–125.77 · 52w 91.91–215.99 · market cap $5.58B · NGM

## Key facts
- 2 of 80 tracked superinvestors hold CAMT (13F, Q2 2026): 2 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 7 Form 4 filings, $5.1M; 7 not under a Rule 10b5-1 plan ($5.1M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.25 on a 1–5 scale) (12 analysts), mean target USD 172.8 (range 152–200).
- Total return with dividends: 1Y +1.2% vs S&P 500 +14.9%; 5Y +209.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.99, revenue estimate $161M.

## Superinvestors (SEC 13F-HR, Q2 2026)
2 of 80 tracked investors hold CAMT. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Polen Capital | Polen Capital Management | 0.01% | $671K | New position |
| Lee Ainslie | Maverick Capital | 0.01% | $589K | New position |

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 7 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | Geva-Dvash Orit | Vice President, HR | 508 | $89K | 8.9% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-13…2026-08-14 | Andorn Karni Yarl | Director | 5,532 | $928K | 80.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-13 | Langer Ram | Chief Operating Officer | 6,387 | $1.1M | 26.7% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-13 | Amit Rafi | Chief Executive Officer | 6,250 | $1.1M | 10.1% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-12 | Geva-Dvash Orit | Vice President, HR | 415 | $72K | 6.8% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11…2026-08-12 | Aviram Lior | Director | 6,694 | $1.1M | 34.8% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11…2026-08-12 | Eisenberg Moshe | Chief Financial Officer | 4,404 | $713K | 21.3% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.25 on a 1–5 scale), 12 analysts; mean target USD 172.8 (low 152, high 200).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | B. Riley Securities | Target lowered | Buy | $200 → $166 |
| 2026-10-16 | Needham | Target lowered | Buy | $190 → $170 |
| 2026-09-28 | Morgan Stanley | Target lowered | Equal-Weight | $165 → $152 |
| 2026-08-11 | Morgan Stanley | Target lowered | Equal-Weight | $167 → $165 |
| 2026-07-06 | Morgan Stanley | Target raised | Equal-Weight | $163 → $167 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +1.2% | +209.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +1.2% | +25.3% |
| Volatility (annualized) | 71.0% | 54.2% |
| Max drawdown | -42.4% (May 2026→Oct 2026) | -61.8% (Jul 2024→Mar 2025) |

## Peers (Semiconductor Equipment & Materials)
FORM (FormFactor, Inc.) USD 95.03 -15.29% · KLIC (Kulicke and Soffa Industries, I) USD 73.4 -9.86% · ACMR (ACM Research, Inc.) USD 49.12 -10.18% · AXTI (AXT Inc) USD 51.56 -13.02% · ACLS (Axcelis Technologies, Inc.) USD 104.74 -10.16% · AMKR (Amkor Technology, Inc.) USD 39.05 -10.70%

## More
Full page: https://nexqual.com/CAMT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in CAMT's own 20-F filed 2026-03-19 (https://www.sec.gov/Archives/edgar/data/1109138/000117891326001561/zk2634678.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Priortech | "We also entered into a Second Amended and Restated Registration Rights Agreement with Priortech and Chroma, according" |
| Partner | Chroma ATE | "We also entered into a Second Amended and Restated Registration Rights Agreement with Priortech and Chroma, according" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.99 | $0.93 | +6.4% | $160.6M | 10 |
| Next quarter (ends 2026-12-31) | $1.17 | $1.11 | +4.9% | $180.0M | 9 |
| Current fiscal year (ends 2026-12-31) | $3.63 | $3.50 | +3.7% | $595.4M | 10 |
| Next fiscal year (ends 2027-12-31) | $5.08 | $4.48 | +13.4% | $800.9M | 10 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-11-04): ±18.2%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 81.1% | ±18.2% |
| 2026-12-18 | 56 | 74.7% | ±23.5% |
| 2027-01-15 | 84 | 73.2% | ±28.1% |
| 2027-02-19 | 119 | 72.3% | ±32.7% |
| 2027-05-21 | 210 | 69.4% | ±41.1% |